Addressing challenges with real-world synthetic control arms to demonstrate the comparative effectiveness of Pralsetinib in non-small cell lung cancer

As advanced non-small cell lung cancer (aNSCLC) is being increasingly divided into rare oncogene-driven subsets, conducting randomised trials becomes challenging. Using real-world data (RWD) to construct control arms for single-arm trials provides an option for comparative data. However, non-randomi...

Descripción completa

Detalles Bibliográficos
Autores principales: Popat, Sanjay, Liu, Stephen V., Scheuer, Nicolas, Hsu, Grace G., Lockhart, Alexandre, Ramagopalan, Sreeram V., Griesinger, Frank, Subbiah, Vivek
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205915/
https://www.ncbi.nlm.nih.gov/pubmed/35715405
http://dx.doi.org/10.1038/s41467-022-30908-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205915/
https://www.ncbi.nlm.nih.gov/pubmed/35715405
http://dx.doi.org/10.1038/s41467-022-30908-1

Ejemplares similares